Lung Transplant

A lung transplant is one of the most complex and consequential procedures in modern medicine, offering patients with end-stage lung disease a meaningful extension of life and a profound improvement in quality of living. It is typically considered when all other medical and surgical treatment options have been exhausted and the lungs can no longer sustain adequate respiratory function.

First performed in the United States in 1963, lung transplantation remains a relatively rare procedure globally, owing to the limited availability of suitable donor organs. India has steadily developed its transplant capabilities, with internationally accredited centres now performing this surgery to the highest clinical standards.

At Global Health Opulence, we work exclusively with specialist transplant centres that combine experienced multi-disciplinary teams, advanced technology, and robust post-transplant care programmes. Our dedicated concierge team coordinates every element of the patient journey, from initial evaluation and waitlisting through to long-term follow-up support after the patient returns home.

The Lungs: Structure and Function

The lungs are a pair of cone-shaped, sponge-like organs situated on either side of the chest cavity. They extend from the level of the collarbone down to the lower ribs, and are enclosed in a protective double-layered membrane called the pleura. The heart occupies the space between the two lungs, positioned slightly to the left of centre.

The primary function of the lungs is the continuous exchange of gases: drawing oxygen from inhaled air into the bloodstream, and removing carbon dioxide from the blood for exhalation. Air enters through the trachea (windpipe), is distributed into each lung through the bronchial tubes, and ultimately reaches the alveoli, microscopic air sacs where gas exchange takes place. Oxygen passes through the thin alveolar walls into the surrounding capillaries and is transported throughout the body, while carbon dioxide makes the reverse journey to be expelled with each breath.

Beyond their respiratory role, the lungs also help regulate blood pH by controlling the concentration of carbon dioxide, convert angiotensin I to angiotensin II to assist in blood pressure regulation, and filter small gas bubbles from the circulation.

Conditions That May Lead to Lung Transplant

Lung transplantation is considered for patients with end-stage lung disease that is progressive, life-limiting, and no longer responsive to medical therapy. The most common underlying conditions include:

Chronic Obstructive Pulmonary Disease (COPD)

COPD is a progressive condition in which structural damage to the lungs results in increasingly impaired airflow and breathing difficulty. It is most commonly caused by long-term tobacco smoking and encompasses two overlapping conditions. Emphysema involves the destruction of the walls between the alveoli, causing air to become trapped in the lungs and significantly reducing gas exchange capacity. Chronic bronchitis involves persistent inflammation and narrowing of the airways, producing chronic cough, excess mucus production, and progressive breathlessness. When COPD reaches an advanced stage and medications are no longer effective, lung transplant may be considered.

Pulmonary Fibrosis

Pulmonary fibrosis is an interstitial lung disease characterised by progressive scarring and thickening of the lung tissue. As the tissue stiffens, the lungs lose their ability to expand and contract normally, making it increasingly difficult to breathe and to maintain adequate oxygen levels. The underlying cause is often unknown (idiopathic pulmonary fibrosis) and there is currently no cure. Lung transplant offers the most effective means of extending survival in appropriately selected patients with advanced disease.

Pulmonary Arterial Hypertension

Pulmonary arterial hypertension is a serious condition in which the arteries connecting the heart to the lungs become narrowed, causing abnormally elevated pressure in the pulmonary circulation. The heart must work significantly harder to pump blood through the constricted vessels, leading to right heart strain, reduced oxygen delivery to the body, and progressive functional decline. While medications can help manage symptoms and slow progression, there is currently no curative treatment, and lung transplant may ultimately be required in advanced cases.

Cystic Fibrosis

Cystic fibrosis is a genetic condition caused by a defective gene that leads to the production of abnormally thick, sticky mucus throughout the body. In the lungs, this mucus obstructs the airways and creates a chronic environment susceptible to recurrent infections, progressive inflammation, and irreversible lung damage. While physiotherapy, medications, and newer disease-modifying therapies can significantly improve quality of life and slow deterioration, end-stage cystic fibrosis may eventually require bilateral lung transplantation.

The Pre-Transplant Evaluation Process

Lung transplantation requires an extensive and multi-disciplinary pre-operative evaluation to confirm that the patient is an appropriate candidate, to optimise their condition before surgery, and to identify a suitably matched donor organ. This evaluation is coordinated by a dedicated transplant team that typically includes a transplant surgeon, transplant pulmonologist, specialist nurses, an anaesthesiologist, a social worker, a psychiatrist, a dietician, and additional support staff as required.

The evaluation process encompasses:

• Comprehensive pulmonary function testing to quantify the degree of respiratory impairment
• CT imaging of the chest to assess lung architecture and identify structural abnormalities
• Echocardiography and cardiac assessment to evaluate right heart function
• Extensive blood work, including blood group typing and tissue matching to identify compatible donors
• Psychological and psychiatric assessment to evaluate emotional resilience, coping capacity, and the patient's understanding of the procedure and its demands
• Nutritional assessment and optimisation
• Review and completion of required immunisations to reduce post-transplant infection risk
• Mandatory cessation of smoking for a defined period before listing is confirmed

Patients who meet the clinical criteria are placed on a transplant waiting list and notified when a compatible donor organ becomes available. Priority is assigned based on medical urgency and compatibility. In exceptional circumstances, donation from a living donor may also be considered.

The Surgical Procedure

In the period immediately before surgery, the patient is prepared by the transplant team, a consent form is signed, dietary restrictions are observed, and sedatives may be administered. A mandatory period of pre-operative hospitalisation allows the team to stabilise the patient and complete all final preparations.

In the operating theatre, an intravenous line is placed and general anaesthesia is administered. Monitoring catheters are inserted at the neck, wrist, or beneath the collarbone to provide continuous assessment of the patient's haemodynamic status throughout the operation.

Depending on whether a single or bilateral transplant is being performed, corresponding incisions are made and the diseased lung or lungs are carefully removed. The donor lung is then positioned and the bronchial airways, pulmonary arteries, and pulmonary veins are meticulously anastomosed (surgically connected) to the patient's existing structures. In some cases, the patient is placed on a cardiopulmonary bypass machine or extracorporeal membrane oxygenation (ECMO) during the procedure to maintain oxygenation while the new lung is being connected.

Once the new airways and vessels have been secured and the transplanted lung is confirmed to be functioning, the chest is closed with sutures. A catheter may be placed to deliver post-operative pain medication directly and effectively.

Post-Operative Care and Hospital Stay

Following surgery, the patient is transferred directly to the Intensive Care Unit, where close monitoring of respiratory, cardiovascular, and renal function is maintained for several days. The ICU phase is critical, as the transplanted lung undergoes its initial integration and the risk of primary graft dysfunction, rejection, and infection is highest in this early window.

As the patient stabilises and the transplanted lung demonstrates adequate function, they are transitioned from the ICU to a specialist ward. Monitoring catheters and respiratory support are progressively removed as recovery allows. The total hospital stay is variable and determined entirely by the individual patient's clinical progress, but typically extends to several weeks for lung transplant recipients.

Recovery and Long-Term Follow-Up

Recovery from a lung transplant is a gradual, carefully monitored process that continues for many months after discharge. The post-transplant period is characterised by a rigorous follow-up schedule that is non-negotiable for long-term graft survival. Routine monitoring includes:

• Regular pulmonary function testing to assess the ongoing performance of the transplanted lung
• Chest X-rays and CT imaging to monitor for infection, rejection, and structural changes
• Blood tests to measure immunosuppressant drug levels and monitor organ function
• Bronchoscopy and biopsy where indicated to detect early signs of rejection or infection

Lifelong immunosuppressive therapy is required to prevent the immune system from rejecting the transplanted organ. The treating team will manage the precise regimen of medications, balancing adequate immune suppression against the risk of infection and other side effects.

Wound care at home must be meticulous: the incision site should be kept clean and dry at all times. Patients must contact their transplant team without delay if any of the following arise:

• High fever or unexplained chills
• Increasing pain, redness, or swelling around the incision
• Fluid leaking from the wound
• Worsening breathlessness or new difficulty breathing
• Persistent cough or new chest pain

Potential Risks and Considerations

Lung transplantation is a major surgical procedure with significant associated risks. These will be discussed comprehensively by the transplant team during the evaluation process. Known risks include:

• Post-operative infection, including bacterial, viral, and fungal pathogens, to which immunosuppressed patients are particularly susceptible
• Deep vein thrombosis or pulmonary embolism
• Primary graft dysfunction in the immediate post-operative period
• Acute or chronic rejection of the transplanted lung by the recipient's immune system
• Severe pulmonary oedema
• Airway complications including narrowing (stenosis) or dehiscence at the bronchial anastomosis
• Vascular complications affecting the pulmonary arteries or veins
• Side effects of long-term immunosuppressive therapy, including increased susceptibility to infection, kidney impairment, and certain malignancies

The transplant team will discuss the individual risk profile in full before listing is confirmed. Patients are encouraged to ask detailed questions and to ensure they have a thorough understanding of the commitments and challenges involved in both the surgery and the lifelong post-transplant care regime.

Maintaining Lung Health

For patients who have not yet reached the stage of requiring a transplant, and for those in recovery, protecting lung function is a primary priority. Evidence-based recommendations for lung health include:

• Ceasing tobacco smoking without delay. Smoking is the single most preventable cause of COPD and lung cancer and is an absolute contraindication to transplant listing.
• Minimising exposure to airborne pollutants, including industrial chemicals, second-hand smoke, vehicle exhaust, and other environmental toxins. Appropriate respiratory protection should be worn in high-exposure environments.
• Screening for radon gas in the home, as radon is the second leading cause of lung cancer and is colourless and odourless, making it undetectable without specialist testing equipment.
• Engaging in regular physical activity, which strengthens the cardiovascular and respiratory systems, improves oxygen delivery efficiency, and supports overall immune function.
• Maintaining up-to-date immunisations, including annual influenza vaccination and pneumococcal vaccination, which are particularly important for patients with pre-existing lung conditions.

How GHO Supports Your Journey

Lung transplantation demands not only exceptional surgical expertise, but also a robust infrastructure of pre-operative evaluation, post-operative monitoring, and long-term immunological management. Global Health Opulence works exclusively with specialist transplant centres that meet the highest standards of accreditation, clinical experience, and patient outcomes. Our concierge team provides end-to-end coordination of the entire patient journey, from the initial clinical enquiry and medical record review, through evaluation and waitlisting, to travel and accommodation logistics, in-country support, and comprehensive virtual follow-up after the patient returns home. Every step is handled with the precision, sensitivity, and discretion that a procedure of this magnitude demands.

Frequently Asked Questions